Clinical trials
Diabetes Mellitus clinical trials
Below are recruiting diabetes mellitus clinical trials, each written for real people, not researchers. We’re tracking 867 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05156736Recruiting
Study of early heart artery disease in South Asians
This study looks at early buildup of plaque in heart arteries in young adults from Pakistan. It may help doctors understand why this happens earlier and guide better prevention and screening.
Karachi, SindhAges 35–65 - NCT02169518Recruiting
Testing blood fat markers in diabetes and heart health
This study measures how certain blood “fat” markers relate to blood sugar control and inflammation. It may help researchers understand risk factors for heart disease in people with type 1 or type 2 diabetes, pre-diabetes, and people preparing for weight-loss surgery.
Manchester, LancashireAges 20–75 - NCT04529889Recruiting
Study of gestational diabetes during pregnancy and child outcomes
This study follows pregnant people with gestational diabetes to see how it affects mothers and babies over time. The team may use this information to better understand risks and care for both you and your child.
Guangzhou, GuangdongAges Any age - NCT06450730Recruiting
Smartphone support program for young people with type 1 diabetes
This study tests a smartphone app plus talk therapy to help young people with type 1 diabetes feel better emotionally. You would use the app and have virtual sessions to learn ways to cope with diabetes.
Córdoba, CórdobaAges 6–18 - NCT06215352Recruiting
Meal timing and blood sugar during pregnancy
This study looks at how when and what you eat during early pregnancy affects your blood sugar levels. It may help find ways to improve glucose control for expecting mothers.
Taipei, Zhongzheng DistrictAges 20 years+ - NCT07873320Enrolling by invitation
Cortisol levels in hard-to-control type 2 diabetes
This study looks for high cortisol levels in people with type 2 diabetes that is difficult to control despite multiple medications. If high cortisol is found, it may point to a condition that can be treated, possibly improving blood sugar control.
Asyut, Asyut GovernorateAges 18–70 - NCT06277466Recruiting
Gene changes and diabetes risk study
This study looks at how certain gene changes affect blood sugar control in type 2 diabetes and also in people who have had pancreas surgery. It compares these groups with healthy volunteers to see how genes influence the risk of diabetes.
XuzhouAges 25–70 - NCT06273761Recruiting
Medication management service for diabetes and high blood pressure
This study tests a medication management service for people with type 2 diabetes and/or high blood pressure who take many medications. It aims to help you better manage your medicines and avoid urgent medical visits.
Hong KongAges 18 years+ - NCT07861191Recruiting
Using continuous glucose monitors to improve insulin sensitivity
This study tests whether using a continuous glucose monitor (CGM) helps people without diabetes improve their insulin sensitivity. You would wear a small sensor that tracks your glucose levels in real time, and the study may help you understand how your body responds to food and activity.
Singapore, SingaporeAges 21–70 - NCT06305195Recruiting
Heart rate and risk in metabolic syndrome
This trial looks at how heart rate variability relates to heart disease risk in people with and without diabetes or pre-diabetes. It may help understand which patients need closer monitoring.
AlexandriaAges 18–70 - NCT03851627RecruitingPhase 4
Testosterone for fatty liver in overweight men with diabetes
This trial compares testosterone undecanoate versus a placebo (inactive pill) to see if it lowers fat in the liver measured by MRI. It focuses on overweight or obese men who have prediabetes or type 2 diabetes and low testosterone confirmed by blood tests.
ViennaAges 18–75 - NCT06305208Recruiting
UK registry for weight loss endoscopy procedures
This study collects information from patients in the UK who have a weight loss procedure done through an endoscope (a thin tube down the throat). It helps doctors learn more about how well these procedures work and how safe they are.
LondonAges 18–99 - NCT06310148Recruiting
Preventing chronic disease in Hong Kong adults aged 45+
This study looks at a new program in Hong Kong that helps people without diabetes or hypertension learn how to prevent or manage chronic diseases. One group gets extra support through a local health centre, and the other group follows usual care.
Hong KongAges 45 years+ - NCT06334172Recruiting
Can oxytocin control blood sugar?
This trial tests if the hormone oxytocin helps control blood sugar levels. It may offer insight into new ways to manage glucose. You may be a good fit if you are a healthy adult with a normal BMI.
Hellerup, Capital RegionAges 20–50 - NCT06396871Recruiting
Blood cell study in metabolic diseases
This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.
Dresden, SaxonyAges 18 years+ - NCT03323216Recruiting
Testing heart-related blood markers in people with diabetes and heart failure
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
Aachen, North Rhine-WestphaliaAges 18 years+ - NCT06449833RecruitingPhase 4
Henagliflozin for liver fat in diabetes and fatty liver
This study tests whether a medicine called henagliflozin can help reduce fat in the liver for people with type 2 diabetes and non-alcoholic fatty liver disease. It may help improve liver health and blood sugar control at the same time.
Guangzhou, GuangdongAges 18–75 - NCT07803809RecruitingPhase 1
MWN105 injection for overweight and obesity
This study tests an investigational injection called MWN105 in people who are overweight or obese but do not have diabetes. The goal is to see if it is safe and helps with weight loss.
Kunming, YunnanAges 18–50 - NCT07807059RecruitingPhase 1
Study of HRS-4729 injection in healthy people and those with kidney problems
This study is testing a new injectable medicine (HRS-4729) to see how the body processes it in people with healthy kidneys and in those with kidney problems. If you join, you will receive a single dose and have your blood and urine checked over time to measure the drug levels.
Chengdu, SichuanAges 18–65 - NCT07799961Recruiting
Connecting social services with healthcare for better health
This study tests a program that helps connect people with social services like food, housing, and transportation through their healthcare provider. It aims to improve health by addressing social needs.
Tucson, ArizonaAges 18 years+ - NCT07784725RecruitingPhase 3
Study of a weight loss injection for adults with obesity
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
Dothan, AlabamaAges 18 years+ - NCT07783802RecruitingPhase 2
Study of clazakizumab for adults with high inflammation and heart risk
This study tests whether clazakizumab can reduce the risk of heart attacks or strokes in people with high levels of inflammation (measured by a blood test called hsCRP) and conditions like heart disease, obesity, diabetes, high blood pressure, or kidney disease. If you qualify, you'll receive either the study drug or a placebo to see if it helps lower your risk.
Huntsville, AlabamaAges 18 years+ - NCT07779343Recruiting
Multidisciplinary support for adults living with obesity
This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.
AlgiersAges 18–65 - NCT07775404RecruitingPhase 3
Weight loss medication for Asian adults with obesity or overweight
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
BaotouAges 18 years+
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus?
- Yes. Clin2 currently lists 867 recruiting diabetes mellitus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.